Dr Misbah Nusrat Shafiq, OD - Medicare Optometrist in Aspen Hill, MD

Dr Misbah Nusrat Shafiq, OD is a medicare enrolled "Optometrist" provider in Aspen Hill, Maryland. She went to New England College Of Optometry and graduated in 2020 and has 4 years of diverse experience with area of expertise as Optometry. She is a member of the group practice Washington Eye Institute, Llc, Kentlands Optometry Llc, Frederick Optometry Llc and her current practice location is 13505 Connecticut Ave, Aspen Hill, Maryland. You can reach out to her office (for appointments etc.) via phone at (301) 438-0555.

Dr Misbah Nusrat Shafiq is licensed to practice in Maryland (license number TA2855) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1821670183.

Contact Information

Dr Misbah Nusrat Shafiq, OD
13505 Connecticut Ave,
Aspen Hill, MD 20906-2912
(301) 438-0555
(301) 438-0556



Healthcare Provider's Profile

Full NameDr Misbah Nusrat Shafiq
GenderFemale
SpecialityOptometry
Experience4 Years
Location13505 Connecticut Ave, Aspen Hill, Maryland
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Misbah Nusrat Shafiq attended and graduated from New England College Of Optometry in 2020
  NPI Data:
  • NPI Number: 1821670183
  • Provider Enumeration Date: 04/26/2021
  • Last Update Date: 12/15/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 9931506581
  • Enrollment ID: I20230417001247

Medical Identifiers

Medical identifiers for Dr Misbah Nusrat Shafiq such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1821670183NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist AT4560 (Oregon)Secondary
152W00000XOptometrist TA2855 (Maryland)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Washington Eye Institute, Llc18504620379
Kentlands Optometry Llc63050944342
Frederick Optometry Llc62040984116

News Archive

Study finds decline in number of clinical trials funded by NIH

The number of clinical trials funded by the National Institutes of Health has declined since 2005, according to a new study by researchers at the Johns Hopkins Bloomberg School of Public Health. During the same period, average trial sizes were observed to be smaller with only 10 percent of trials enrolling more than 500 participants.

Researchers decode factors that contribute to risk of developing motor neuron disease

Trinity College Dublin researchers have found that one in 347 men and one in 436 women can be expected to develop motor neuron disease during their lifetime.

Eldelumab and Fenofibrate show potential for COVID-19

In a new study posted to the medRxiv* preprint server, researchers from the University of Pittsburgh and Barrow Neurological Institute report the results of their analysis of several RNA-Seq studies and used computational approaches to discover potential drugs against COVID-19.

SafeMinds disappointed with CDC's report on autism spectrum disorders

A study released Friday by the Centers for Disease Control (CDC) reported that autism prevalence has increased a staggering 57% from the 1994 rate of 1 in 150 to 1 in 110 for children born in 1996. SafeMinds is extremely dissatisfied with CDC's lack of commitment to researching environmental causes and the timing of their announcement.

RNA affecting skin cancer progression discovered

Researchers at the University of Turku, Turku University Central Hospital, and Western Cancer Center have discovered a new RNA molecule, PRECSIT, which regulates the growth and invasion of squamous cell carcinoma of the skin.

Read more Medical News

› Verified 2 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Misbah Nusrat Shafiq allows following entities to bill medicare on her behalf.
Provider NameSilver Spring Optometry, Llc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1336204387
PECOS PAC ID: 1951351626
Enrollment ID: O20050131000340

News Archive

Study finds decline in number of clinical trials funded by NIH

The number of clinical trials funded by the National Institutes of Health has declined since 2005, according to a new study by researchers at the Johns Hopkins Bloomberg School of Public Health. During the same period, average trial sizes were observed to be smaller with only 10 percent of trials enrolling more than 500 participants.

Researchers decode factors that contribute to risk of developing motor neuron disease

Trinity College Dublin researchers have found that one in 347 men and one in 436 women can be expected to develop motor neuron disease during their lifetime.

Eldelumab and Fenofibrate show potential for COVID-19

In a new study posted to the medRxiv* preprint server, researchers from the University of Pittsburgh and Barrow Neurological Institute report the results of their analysis of several RNA-Seq studies and used computational approaches to discover potential drugs against COVID-19.

SafeMinds disappointed with CDC's report on autism spectrum disorders

A study released Friday by the Centers for Disease Control (CDC) reported that autism prevalence has increased a staggering 57% from the 1994 rate of 1 in 150 to 1 in 110 for children born in 1996. SafeMinds is extremely dissatisfied with CDC's lack of commitment to researching environmental causes and the timing of their announcement.

RNA affecting skin cancer progression discovered

Researchers at the University of Turku, Turku University Central Hospital, and Western Cancer Center have discovered a new RNA molecule, PRECSIT, which regulates the growth and invasion of squamous cell carcinoma of the skin.

Read more Medical News

› Verified 2 days ago

Provider NameRockville Pike Optometry, Llc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1710043278
PECOS PAC ID: 4688776313
Enrollment ID: O20070226000722

News Archive

Study finds decline in number of clinical trials funded by NIH

The number of clinical trials funded by the National Institutes of Health has declined since 2005, according to a new study by researchers at the Johns Hopkins Bloomberg School of Public Health. During the same period, average trial sizes were observed to be smaller with only 10 percent of trials enrolling more than 500 participants.

Researchers decode factors that contribute to risk of developing motor neuron disease

Trinity College Dublin researchers have found that one in 347 men and one in 436 women can be expected to develop motor neuron disease during their lifetime.

Eldelumab and Fenofibrate show potential for COVID-19

In a new study posted to the medRxiv* preprint server, researchers from the University of Pittsburgh and Barrow Neurological Institute report the results of their analysis of several RNA-Seq studies and used computational approaches to discover potential drugs against COVID-19.

SafeMinds disappointed with CDC's report on autism spectrum disorders

A study released Friday by the Centers for Disease Control (CDC) reported that autism prevalence has increased a staggering 57% from the 1994 rate of 1 in 150 to 1 in 110 for children born in 1996. SafeMinds is extremely dissatisfied with CDC's lack of commitment to researching environmental causes and the timing of their announcement.

RNA affecting skin cancer progression discovered

Researchers at the University of Turku, Turku University Central Hospital, and Western Cancer Center have discovered a new RNA molecule, PRECSIT, which regulates the growth and invasion of squamous cell carcinoma of the skin.

Read more Medical News

› Verified 2 days ago

Provider NameRockville Optometry, Llc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1548325798
PECOS PAC ID: 8729180112
Enrollment ID: O20070305000335

News Archive

Study finds decline in number of clinical trials funded by NIH

The number of clinical trials funded by the National Institutes of Health has declined since 2005, according to a new study by researchers at the Johns Hopkins Bloomberg School of Public Health. During the same period, average trial sizes were observed to be smaller with only 10 percent of trials enrolling more than 500 participants.

Researchers decode factors that contribute to risk of developing motor neuron disease

Trinity College Dublin researchers have found that one in 347 men and one in 436 women can be expected to develop motor neuron disease during their lifetime.

Eldelumab and Fenofibrate show potential for COVID-19

In a new study posted to the medRxiv* preprint server, researchers from the University of Pittsburgh and Barrow Neurological Institute report the results of their analysis of several RNA-Seq studies and used computational approaches to discover potential drugs against COVID-19.

SafeMinds disappointed with CDC's report on autism spectrum disorders

A study released Friday by the Centers for Disease Control (CDC) reported that autism prevalence has increased a staggering 57% from the 1994 rate of 1 in 150 to 1 in 110 for children born in 1996. SafeMinds is extremely dissatisfied with CDC's lack of commitment to researching environmental causes and the timing of their announcement.

RNA affecting skin cancer progression discovered

Researchers at the University of Turku, Turku University Central Hospital, and Western Cancer Center have discovered a new RNA molecule, PRECSIT, which regulates the growth and invasion of squamous cell carcinoma of the skin.

Read more Medical News

› Verified 2 days ago

Provider NameMiller Eyecare Olney, Llc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1366507303
PECOS PAC ID: 5799871638
Enrollment ID: O20071023000604

News Archive

Study finds decline in number of clinical trials funded by NIH

The number of clinical trials funded by the National Institutes of Health has declined since 2005, according to a new study by researchers at the Johns Hopkins Bloomberg School of Public Health. During the same period, average trial sizes were observed to be smaller with only 10 percent of trials enrolling more than 500 participants.

Researchers decode factors that contribute to risk of developing motor neuron disease

Trinity College Dublin researchers have found that one in 347 men and one in 436 women can be expected to develop motor neuron disease during their lifetime.

Eldelumab and Fenofibrate show potential for COVID-19

In a new study posted to the medRxiv* preprint server, researchers from the University of Pittsburgh and Barrow Neurological Institute report the results of their analysis of several RNA-Seq studies and used computational approaches to discover potential drugs against COVID-19.

SafeMinds disappointed with CDC's report on autism spectrum disorders

A study released Friday by the Centers for Disease Control (CDC) reported that autism prevalence has increased a staggering 57% from the 1994 rate of 1 in 150 to 1 in 110 for children born in 1996. SafeMinds is extremely dissatisfied with CDC's lack of commitment to researching environmental causes and the timing of their announcement.

RNA affecting skin cancer progression discovered

Researchers at the University of Turku, Turku University Central Hospital, and Western Cancer Center have discovered a new RNA molecule, PRECSIT, which regulates the growth and invasion of squamous cell carcinoma of the skin.

Read more Medical News

› Verified 2 days ago

Provider NameBethesda Optometry, Llc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1568687028
PECOS PAC ID: 3577647460
Enrollment ID: O20080303000203

News Archive

Study finds decline in number of clinical trials funded by NIH

The number of clinical trials funded by the National Institutes of Health has declined since 2005, according to a new study by researchers at the Johns Hopkins Bloomberg School of Public Health. During the same period, average trial sizes were observed to be smaller with only 10 percent of trials enrolling more than 500 participants.

Researchers decode factors that contribute to risk of developing motor neuron disease

Trinity College Dublin researchers have found that one in 347 men and one in 436 women can be expected to develop motor neuron disease during their lifetime.

Eldelumab and Fenofibrate show potential for COVID-19

In a new study posted to the medRxiv* preprint server, researchers from the University of Pittsburgh and Barrow Neurological Institute report the results of their analysis of several RNA-Seq studies and used computational approaches to discover potential drugs against COVID-19.

SafeMinds disappointed with CDC's report on autism spectrum disorders

A study released Friday by the Centers for Disease Control (CDC) reported that autism prevalence has increased a staggering 57% from the 1994 rate of 1 in 150 to 1 in 110 for children born in 1996. SafeMinds is extremely dissatisfied with CDC's lack of commitment to researching environmental causes and the timing of their announcement.

RNA affecting skin cancer progression discovered

Researchers at the University of Turku, Turku University Central Hospital, and Western Cancer Center have discovered a new RNA molecule, PRECSIT, which regulates the growth and invasion of squamous cell carcinoma of the skin.

Read more Medical News

› Verified 2 days ago

Provider NameWashington Eye Institute, Llc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1740450816
PECOS PAC ID: 1850462037
Enrollment ID: O20080616000378

News Archive

Study finds decline in number of clinical trials funded by NIH

The number of clinical trials funded by the National Institutes of Health has declined since 2005, according to a new study by researchers at the Johns Hopkins Bloomberg School of Public Health. During the same period, average trial sizes were observed to be smaller with only 10 percent of trials enrolling more than 500 participants.

Researchers decode factors that contribute to risk of developing motor neuron disease

Trinity College Dublin researchers have found that one in 347 men and one in 436 women can be expected to develop motor neuron disease during their lifetime.

Eldelumab and Fenofibrate show potential for COVID-19

In a new study posted to the medRxiv* preprint server, researchers from the University of Pittsburgh and Barrow Neurological Institute report the results of their analysis of several RNA-Seq studies and used computational approaches to discover potential drugs against COVID-19.

SafeMinds disappointed with CDC's report on autism spectrum disorders

A study released Friday by the Centers for Disease Control (CDC) reported that autism prevalence has increased a staggering 57% from the 1994 rate of 1 in 150 to 1 in 110 for children born in 1996. SafeMinds is extremely dissatisfied with CDC's lack of commitment to researching environmental causes and the timing of their announcement.

RNA affecting skin cancer progression discovered

Researchers at the University of Turku, Turku University Central Hospital, and Western Cancer Center have discovered a new RNA molecule, PRECSIT, which regulates the growth and invasion of squamous cell carcinoma of the skin.

Read more Medical News

› Verified 2 days ago

Provider NameAspen Hill Optometry, Llc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1629293170
PECOS PAC ID: 4486716420
Enrollment ID: O20081229000373

News Archive

Study finds decline in number of clinical trials funded by NIH

The number of clinical trials funded by the National Institutes of Health has declined since 2005, according to a new study by researchers at the Johns Hopkins Bloomberg School of Public Health. During the same period, average trial sizes were observed to be smaller with only 10 percent of trials enrolling more than 500 participants.

Researchers decode factors that contribute to risk of developing motor neuron disease

Trinity College Dublin researchers have found that one in 347 men and one in 436 women can be expected to develop motor neuron disease during their lifetime.

Eldelumab and Fenofibrate show potential for COVID-19

In a new study posted to the medRxiv* preprint server, researchers from the University of Pittsburgh and Barrow Neurological Institute report the results of their analysis of several RNA-Seq studies and used computational approaches to discover potential drugs against COVID-19.

SafeMinds disappointed with CDC's report on autism spectrum disorders

A study released Friday by the Centers for Disease Control (CDC) reported that autism prevalence has increased a staggering 57% from the 1994 rate of 1 in 150 to 1 in 110 for children born in 1996. SafeMinds is extremely dissatisfied with CDC's lack of commitment to researching environmental causes and the timing of their announcement.

RNA affecting skin cancer progression discovered

Researchers at the University of Turku, Turku University Central Hospital, and Western Cancer Center have discovered a new RNA molecule, PRECSIT, which regulates the growth and invasion of squamous cell carcinoma of the skin.

Read more Medical News

› Verified 2 days ago

Provider NameMiller Eye Care Center, Llc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1588729719
PECOS PAC ID: 6103989496
Enrollment ID: O20090113000462

News Archive

Study finds decline in number of clinical trials funded by NIH

The number of clinical trials funded by the National Institutes of Health has declined since 2005, according to a new study by researchers at the Johns Hopkins Bloomberg School of Public Health. During the same period, average trial sizes were observed to be smaller with only 10 percent of trials enrolling more than 500 participants.

Researchers decode factors that contribute to risk of developing motor neuron disease

Trinity College Dublin researchers have found that one in 347 men and one in 436 women can be expected to develop motor neuron disease during their lifetime.

Eldelumab and Fenofibrate show potential for COVID-19

In a new study posted to the medRxiv* preprint server, researchers from the University of Pittsburgh and Barrow Neurological Institute report the results of their analysis of several RNA-Seq studies and used computational approaches to discover potential drugs against COVID-19.

SafeMinds disappointed with CDC's report on autism spectrum disorders

A study released Friday by the Centers for Disease Control (CDC) reported that autism prevalence has increased a staggering 57% from the 1994 rate of 1 in 150 to 1 in 110 for children born in 1996. SafeMinds is extremely dissatisfied with CDC's lack of commitment to researching environmental causes and the timing of their announcement.

RNA affecting skin cancer progression discovered

Researchers at the University of Turku, Turku University Central Hospital, and Western Cancer Center have discovered a new RNA molecule, PRECSIT, which regulates the growth and invasion of squamous cell carcinoma of the skin.

Read more Medical News

› Verified 2 days ago

Provider NameCabin John Optometry Llc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1538307962
PECOS PAC ID: 6800072224
Enrollment ID: O20120905000226

News Archive

Study finds decline in number of clinical trials funded by NIH

The number of clinical trials funded by the National Institutes of Health has declined since 2005, according to a new study by researchers at the Johns Hopkins Bloomberg School of Public Health. During the same period, average trial sizes were observed to be smaller with only 10 percent of trials enrolling more than 500 participants.

Researchers decode factors that contribute to risk of developing motor neuron disease

Trinity College Dublin researchers have found that one in 347 men and one in 436 women can be expected to develop motor neuron disease during their lifetime.

Eldelumab and Fenofibrate show potential for COVID-19

In a new study posted to the medRxiv* preprint server, researchers from the University of Pittsburgh and Barrow Neurological Institute report the results of their analysis of several RNA-Seq studies and used computational approaches to discover potential drugs against COVID-19.

SafeMinds disappointed with CDC's report on autism spectrum disorders

A study released Friday by the Centers for Disease Control (CDC) reported that autism prevalence has increased a staggering 57% from the 1994 rate of 1 in 150 to 1 in 110 for children born in 1996. SafeMinds is extremely dissatisfied with CDC's lack of commitment to researching environmental causes and the timing of their announcement.

RNA affecting skin cancer progression discovered

Researchers at the University of Turku, Turku University Central Hospital, and Western Cancer Center have discovered a new RNA molecule, PRECSIT, which regulates the growth and invasion of squamous cell carcinoma of the skin.

Read more Medical News

› Verified 2 days ago

Provider NameKentlands Optometry Llc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1275774234
PECOS PAC ID: 6305094434
Enrollment ID: O20120914000662

News Archive

Study finds decline in number of clinical trials funded by NIH

The number of clinical trials funded by the National Institutes of Health has declined since 2005, according to a new study by researchers at the Johns Hopkins Bloomberg School of Public Health. During the same period, average trial sizes were observed to be smaller with only 10 percent of trials enrolling more than 500 participants.

Researchers decode factors that contribute to risk of developing motor neuron disease

Trinity College Dublin researchers have found that one in 347 men and one in 436 women can be expected to develop motor neuron disease during their lifetime.

Eldelumab and Fenofibrate show potential for COVID-19

In a new study posted to the medRxiv* preprint server, researchers from the University of Pittsburgh and Barrow Neurological Institute report the results of their analysis of several RNA-Seq studies and used computational approaches to discover potential drugs against COVID-19.

SafeMinds disappointed with CDC's report on autism spectrum disorders

A study released Friday by the Centers for Disease Control (CDC) reported that autism prevalence has increased a staggering 57% from the 1994 rate of 1 in 150 to 1 in 110 for children born in 1996. SafeMinds is extremely dissatisfied with CDC's lack of commitment to researching environmental causes and the timing of their announcement.

RNA affecting skin cancer progression discovered

Researchers at the University of Turku, Turku University Central Hospital, and Western Cancer Center have discovered a new RNA molecule, PRECSIT, which regulates the growth and invasion of squamous cell carcinoma of the skin.

Read more Medical News

› Verified 2 days ago

Provider NameGermantown Optometry Llc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1114183910
PECOS PAC ID: 2264681725
Enrollment ID: O20120927000652

News Archive

Study finds decline in number of clinical trials funded by NIH

The number of clinical trials funded by the National Institutes of Health has declined since 2005, according to a new study by researchers at the Johns Hopkins Bloomberg School of Public Health. During the same period, average trial sizes were observed to be smaller with only 10 percent of trials enrolling more than 500 participants.

Researchers decode factors that contribute to risk of developing motor neuron disease

Trinity College Dublin researchers have found that one in 347 men and one in 436 women can be expected to develop motor neuron disease during their lifetime.

Eldelumab and Fenofibrate show potential for COVID-19

In a new study posted to the medRxiv* preprint server, researchers from the University of Pittsburgh and Barrow Neurological Institute report the results of their analysis of several RNA-Seq studies and used computational approaches to discover potential drugs against COVID-19.

SafeMinds disappointed with CDC's report on autism spectrum disorders

A study released Friday by the Centers for Disease Control (CDC) reported that autism prevalence has increased a staggering 57% from the 1994 rate of 1 in 150 to 1 in 110 for children born in 1996. SafeMinds is extremely dissatisfied with CDC's lack of commitment to researching environmental causes and the timing of their announcement.

RNA affecting skin cancer progression discovered

Researchers at the University of Turku, Turku University Central Hospital, and Western Cancer Center have discovered a new RNA molecule, PRECSIT, which regulates the growth and invasion of squamous cell carcinoma of the skin.

Read more Medical News

› Verified 2 days ago

Provider NameMyeyedr Optometry Of Maryland Llc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1497124796
PECOS PAC ID: 6002037629
Enrollment ID: O20151102002293

News Archive

Study finds decline in number of clinical trials funded by NIH

The number of clinical trials funded by the National Institutes of Health has declined since 2005, according to a new study by researchers at the Johns Hopkins Bloomberg School of Public Health. During the same period, average trial sizes were observed to be smaller with only 10 percent of trials enrolling more than 500 participants.

Researchers decode factors that contribute to risk of developing motor neuron disease

Trinity College Dublin researchers have found that one in 347 men and one in 436 women can be expected to develop motor neuron disease during their lifetime.

Eldelumab and Fenofibrate show potential for COVID-19

In a new study posted to the medRxiv* preprint server, researchers from the University of Pittsburgh and Barrow Neurological Institute report the results of their analysis of several RNA-Seq studies and used computational approaches to discover potential drugs against COVID-19.

SafeMinds disappointed with CDC's report on autism spectrum disorders

A study released Friday by the Centers for Disease Control (CDC) reported that autism prevalence has increased a staggering 57% from the 1994 rate of 1 in 150 to 1 in 110 for children born in 1996. SafeMinds is extremely dissatisfied with CDC's lack of commitment to researching environmental causes and the timing of their announcement.

RNA affecting skin cancer progression discovered

Researchers at the University of Turku, Turku University Central Hospital, and Western Cancer Center have discovered a new RNA molecule, PRECSIT, which regulates the growth and invasion of squamous cell carcinoma of the skin.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Misbah Nusrat Shafiq is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Misbah Nusrat Shafiq, OD
8614 Westwood Center Dr Fl 9,
Vienna, VA 22182-2442

Ph: (703) 847-8899
Dr Misbah Nusrat Shafiq, OD
13505 Connecticut Ave,
Aspen Hill, MD 20906-2912

Ph: (301) 438-0555

News Archive

Study finds decline in number of clinical trials funded by NIH

The number of clinical trials funded by the National Institutes of Health has declined since 2005, according to a new study by researchers at the Johns Hopkins Bloomberg School of Public Health. During the same period, average trial sizes were observed to be smaller with only 10 percent of trials enrolling more than 500 participants.

Researchers decode factors that contribute to risk of developing motor neuron disease

Trinity College Dublin researchers have found that one in 347 men and one in 436 women can be expected to develop motor neuron disease during their lifetime.

Eldelumab and Fenofibrate show potential for COVID-19

In a new study posted to the medRxiv* preprint server, researchers from the University of Pittsburgh and Barrow Neurological Institute report the results of their analysis of several RNA-Seq studies and used computational approaches to discover potential drugs against COVID-19.

SafeMinds disappointed with CDC's report on autism spectrum disorders

A study released Friday by the Centers for Disease Control (CDC) reported that autism prevalence has increased a staggering 57% from the 1994 rate of 1 in 150 to 1 in 110 for children born in 1996. SafeMinds is extremely dissatisfied with CDC's lack of commitment to researching environmental causes and the timing of their announcement.

RNA affecting skin cancer progression discovered

Researchers at the University of Turku, Turku University Central Hospital, and Western Cancer Center have discovered a new RNA molecule, PRECSIT, which regulates the growth and invasion of squamous cell carcinoma of the skin.

Read more News

› Verified 2 days ago


Optometrist in Aspen Hill, MD

Jenny Chen,
Optometrist
Medicare: Medicare Enrolled
Practice Location: 13505 Connecticut Ave, Aspen Hill, MD 20906
Phone: 301-438-0555    
Terry Kim, OD
Optometrist
Medicare: May Accept Medicare Assignments
Practice Location: 13505 Connecticut Ave, Aspen Hill, MD 20906
Phone: 301-438-0555    Fax: 301-438-0556
Monique Turnbull, OD
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 13531 Connecticut Ave, Aspen Hill, MD 20906
Phone: 301-438-0555    Fax: 301-438-0556
My Eye Dr
Optometrist
Medicare: Medicare Enrolled
Practice Location: 13505 Connecticut Ave, Aspen Hill, MD 20906
Phone: 301-438-0555    Fax: 301-438-0556
Dr. Kevin William Mathes, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 13505 Connecticut Ave, Aspen Hill, MD 20906
Phone: 301-438-0555    
Daniel L Thomas, OD
Optometrist
Medicare: Medicare Enrolled
Practice Location: 13531 Connecticut Ave, Aspen Hill, MD 20906
Phone: 301-438-0555    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.